The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
then the 60 no each pathway can be proliferative so when we think about estrogen dominance and something that's proliferative we think about like fibroadenomas of the breast fiber in tumors of the you wrists uterine polyps right so these are growths that are not necessarily cancerous but the cells are growing or proliferating
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.